(1 - 10 from 10
)
After Google-Apple, Can Biogen Directors Sit on Genzyme Board?
www.wsj.com
Two of Icahn's four nominees to Genzyme's board already serve as directors at Biogen Idec.
Biogen Profit Rises, Helped by Tysabri - WSJ
www.wsj.com
Biogen profit jumped 34%, helped by cost cuts and higher sales of MS drug Tysabri. But the biotech company trimmed its revenue growth projection.
sorted by relevance / date